CompletedPhase 3NCT03548311
Clinical Trial of Ultra-high Dose Methylcobalamin for ALS
Studying Amyotrophic lateral sclerosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Eisai Co., Ltd.
- Principal Investigator
- Ryuji Kaji, MDTokushima University Hospital
- Intervention
- methylcobalamin(drug)
- Enrollment
- 130 enrolled
- Eligibility
- 20 years · All sexes
- Timeline
- 2017 – 2025
Study locations (16)
- Nagoya University Hospital, Nagoya, Aichi-ken, Japan
- Miyoshi Neurological Clinic, Miyoshi, Hiroshima, Japan
- Sapporo Medical University Hospital, Sapporo, Hokkaido, Japan
- Kobe Central Munincipal Medical center, Kobe, Hyōgo, Japan
- Ioh National Hospital, Kanazawa, Ishikawa-ken, Japan
- Kitasato University East Hospital, Sagamihara, Kanagawa, Japan
- Shiga Medical University Hospital, Ōtsu, Shiga, Japan
- Chiba University Hospital, Chiba, Japan
- Murakami Karindo Hospital, Fukuoka, Japan
- Okayama University Hospital, Okayama, Japan
- Tokushima University Hospital, Tokushima, Japan
- Juntendo University Hospital, Tokyo, Japan
- Toho University Hospital, Tokyo, Japan
- Teikyo University Hospital, Tokyo, Japan
- Tokyo Metropolitan Neurological Hospital, Tokyo, Japan
- +1 more locations on ClinicalTrials.gov
Collaborators
University of Tokushima
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03548311 on ClinicalTrials.govOther trials for Amyotrophic lateral sclerosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07401186Stimulation-Based Modulation of Spinal and Cortical Sensory PathwaysPeter C. Gerszten, MD
- RECRUITINGNCT07467187Invasive Home Ventilation in DenmarkRigshospitalet, Denmark
- RECRUITINGNCT07259980A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD-1) Amyotrophic Lateral Sclerosis (ALS)Biogen
- RECRUITINGNCT07502677Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral SclerosisRoyal Brompton & Harefield NHS Foundation Trust
- RECRUITINGNANCT07446114Functional Outcomes and Control Using Synchron BCI - CanadaSynchron, Inc.
- ENROLLING BY INVITATIONPHASE2, PHASE3NCT07410806HEALEY ALS Platform Trial - Regimen I NUZ-001Merit E. Cudkowicz, MD
- ENROLLING BY INVITATIONNANCT07298486Impact of Robotic Glove Use on Quality of Life, Grip Strength and Fine Motor Control in ALSNova Southeastern University
- ACTIVE NOT RECRUITINGPHASE1NCT07204977Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)National Institute of Neurological Disorders and Stroke (NINDS)